Litigation Details for Bionpharma Inc. v. Corerx, Inc. (2d Cir. 2022)
✉ Email this page to a colleague
Bionpharma Inc. v. Corerx, Inc. (2d Cir. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-02-21 |
Court | Court of Appeals for the Second Circuit | Date Terminated | 2022-05-02 |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Parties | CORERX, INC. | ||
Patents | 10,039,745; 10,154,987; 8,568,747; 9,669,008; 9,808,442 | ||
Attorneys | Jacqueline Marie Weyand, Esq., - | ||
Firms | Direct: 212-440-4488, Buchanan Ingersoll & Rooney PC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Bionpharma Inc. v. Corerx, Inc.
Details for Bionpharma Inc. v. Corerx, Inc. (2d Cir. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-02-24 | 14 | of Azurity’s Epaned® patents (U.S. Patent Nos. 9,669,008, 9,808,442, 10,039,745, 10,154,987, 10,772,…"'442 patent"), 10,039,745 (the "'745 patent"), and 10,154,987 (the "…case are United States Patent Nos. 10,039,745 (the "'745 patent") and 10,154,987 (the…infringes claims 4, 7, and 10 of U.S. Patent No. 10,039,745 (“the ’745 Patent”). 2. Judgment is …’s U.S. Patent Nos. 9,669,008, 9,808,442, 10,039,745, and 10,154,987 (“the First Wave Patents”); | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |